STE GROUP RELEASE
On 18 March 2021, the ROMACO Group acquired STE Tecpharm, a spin-off of the STE Group.
Although STE Tecpharm performed its activity under the scope of the STE brand, since its inception it was a fully independent company that had no shareholding relation with the STE Group owners or with any of the group companies.
Following the announcement of this acquisition, both the owners and the management team of the Group wish to inform you that in no way does this transaction affect our organisation, our philosophy or our strategy. We are in a sector where there is no room for improvising, where actions are mostly long term. We rely on the skills and professionalism of our teams, both at a managerial and operational level. Nothing has changed in the STE Group.
As always, we will continue to develop our specialisation, growth and expansion based on the work, rigour and strength that are the basis of the organisation, both in Spain and in all the countries where the Group is present through subsidiaries, Algeria, Tunisia, Morocco, Colombia, Peru and Paraguay, with teams of qualified professionals that are capable of developing projects and installations of great added value.
With the appointment in January of Xavier Aguilar Beitia as CEO of STE Group, the companies of our Group, including our relationship with the MARCHESINI Group, have an ongoing commitment to becoming a pharmaceutical engineering reference, which will allow us to face the future clearly, always focusing on the business areas that are part of the Group's strategy.
Barcelona, 21 March 2021
Successful projects case studies
GENERAL LEGAL NOTICE
1. Intellectual property of the web.
All the intellectual property rights of the content of this web page, its graphic design and source codes, are the exclusive property of STE ENGIPHARM, S.L. Adress: Avda. Universitat Autònoma, 13 (Parc Tecnològic del Vallès), 08290 Cerdanyola del Vallès C.I.F.B-08.630.048, the exclusive exercise of the rights of exploitation of them corresponding to this company.
Therefore their reproduction, distribution, public communication and transformation, in whole or in part, are prohibited without the express authorization of STE ENGIPHARM, S.L.. Also all the trade names, trade marks or distinguishing signs of any kind contained in this web site are protected by law.
2. Content of the web and links.
STE ENGIPHARM, S.L. cannot be held responsible for the misuse which may be made of the contents of the company web page, this being the exclusive responsibility of the person accessing these contents or using them. Neither can the company accept any responsibility for the information contained in the web pages of third parties which may be accessed through links or searches from the web page www.steengipharm.com
3. Exchange or diffusion of information.
STE ENGIPHARM, S.L. declines all responsibility which may arise from the interchange of information among users through its web page. In particular, the company cannot be responsible for the use that persons under age may make of it in the case that the contents to which they may have access could damage their sensitivity.
4. Updating and amendment of the web page.
STE ENGIPHARM, S.L. reserves the right to update, amend and eliminate the information contained in its website and the configuration and presentation of it at any time, without previous notice, and without assuming any responsibility as a result.
5. Recommendations over technical aspects.
STE ENGIPHARM, S.L. accepts no responsibility which could arise from technical problems or failures of computer equipment not imputable to the company, which may occur during connection to the Internet network, as well as damage which could be caused to third parties through illegitimate intromissions outside the control of STE ENGIPHARM, S.L.
The company is also freed from all responsibility for possible loss and damages which the user could suffer as a consequence of errors, defects and omissions in the information delivered when this is derived from outside sources.
6. Treatment of the users data.
In compliance with the provision in the Constitutional Act 15/1999, of 13 December, of the Protection of Data of a Personal Nature, STE ENGIPHARM, S.L. advises its clients that any personal data supplied to it will be included in an automated file of personal data, created and maintained under the responsibility of STE ENGIPHARM, S.L. The purpose of this file is to send trading offers in the future over the products and services which may be of interest to the companies clients.
STE ENGIPHARM, S.L. guarantees the security and confidentiality of the data delivered. In this way it undertakes compliance with its obligation of secrecy of data of a personal nature and its duty to keep such data and adopt all means necessary to avoid their alteration, loss, treatment or unauthorized use. Therefore, all information regarding the companies clients will not be used for trading proposals or given to third parties.
The clients of STE ENGIPHARM, S.L. may at all times exercise the right of access, rectification, cancellation and opposition, through a communication in writing to the e-mail address: firstname.lastname@example.org
7. Legislation and jurisdiction applicable.
As a general matter, relations with the companies clients which arise from the supply of the services contained in this web are subject to Spanish legislation and jurisdiction.
The users of the companies web are aware of all the above and willingly accept it.